PRESS

Is There any Relationship with Multiple Transfusion and Development of Alloantibodies - An Observational Study

ST Radhiga*; S Kalpana

    All over the world, blood transfusion is the most common procedure performed during a hospitalization. Transfusions, while often life-saving, are not without risk. Alloantibodies are one type of sequela that arises in a subset of Red Blood Cell (RBC) transfusion patients.


Validation of Statistical Quality Controls to Improve HCV Detection: An Efficient Approach for Accurate Diagnosis

Shahid Nadeem; Ali Haider*; Hannana Maryum; Mahnoor Fatima; Umair Waqas; Faiza Maryum; Usman Baig

    HCV is the RNA enveloped virus belonging to the family of flavivirus, causing serious hepatic problems all over the world. While screening for HCV, many of the results false negative or false positive which reach chronic stages of the infection and eventually cancer


Some Markers of Coagulation and Glycemic Control in Type 2 Diabetes Mellitus Patients Based on Gender

Alphonsus Ogbonna Ogbuabor*; Kinsley Ogbonna Ugwu; Basil Ifeanyi Ugwu

    Background: The burden of type 2 diabetes mellitus (T2DM) is increasing worldwide and. It is a leading cause. Due to lack of funds and poor healthcare system, Sub-Saharan Africa is the worst affected with Nigeria bearing the greatest burden for the region. A major factor underlying the development of complication in type 2 diabetes is poor glycemic control and coagulation activation.


A Rare Case of an Acquired Isolated Factor VII Deficiency Discovered in a 23-Year-Old Female Patient

Zahra Kmira*; Sassi Nedia; Ben Yahya Noura; Ncibi Seif; Greisha Ahmed; Mootameri Wided; Bouteraa Walid; Zaier Monia; Ben Youssef Yosra; Brahem Nejia; Haifa Regaieg; Khelif Abderrahim

    Background: Factor VII (FVII) deficiency, a rare bleeding disorder, can manifest as an autosomal recessive congenital or an acquired coagulopathy. Acquired FVII deficiency, although infrequently reported, presents unique challenges in understanding its mechanisms and identifying underlying causes.


Concurrent Therapy of Hepatitis C and Primary CNS Lymphoma: A Case Report

K. Xhaxho*; E. Aydilek; R. Akdas; K. Becker; H. Schwörer; T. Huckhagel; L. Stork; C. Stadelmann; G. Wulf; N. Brökers

    At diagnosis of primary central nervous system lymphoma (PCNSL), the patient was tested positive for hepatitis C. Curative therapy for cerebral lymphoma includes high-dose methotrexate. Direct antiretroviral (DAA) drugs are highly effective in the treatment of hepatitis C.


MedDocs Publishers

We always work towards offering the best to you. For any queries, please feel free to get in touch with us. Also you may post your valuable feedback after reading our journals, ebooks and after visiting our conferences.